Similarly, our study revealed that the expression of KDM5A can also reduce the sensitivity of pancreatic cancer cells to a variety of targeted and chemotherapeutic drugs (such as gemcitabine and paclitaxel). This evidence concerns the gene KDM5A and familial pancreatic carcinoma.